Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas

被引:42
作者
Ishikawa, M
Fujii, T
Masumoto, N
Saito, M
Mukai, M
Nindl, I
Ridder, R
Fukuchi, T
Kubushiro, K
Tsukazaki, K
Nozawa, S
机构
[1] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan
[3] MTM Labs AG, Heidelberg, Germany
关键词
p16(INK4A); uterine cervix; adenocarcinoma; human papillomavirus;
D O I
10.1097/01.pgp.0000092135.88121.1f
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
As human papillomavirus (HPV) infection is the main risk factor for squamous cell carcinoma of the cervix and overexpression of p16(INK4a) occurs when retinoblastoma. protein is inactivated by high-risk HPV, the authors studied the association of HPV infection and expression of p16(INK4a) in cervical adenocarcinomas. Specimens of cervical glandular neoplasias were immunostained with a p16(INK4a)- specific monoclonal antibody (clone E6H4). Approximately 80% of glandular neoplasms showed overexpression of p16(INK4a). Exfoliated cells from 14 adenocarcinomas were further examined by p16(INK4a)-specific immunocytochemistry, and 12 cases showed overexpression of p16(INK4a), suggesting that immunostaining for p16(INK4a) may be a useful diagnostic tool for cervical adenocarcinomas. The authors further examined HPV DNA in cervical adenocarcinomas with the polymerase chain reaction method. Overexpression of p16(INK4a) was positive in 94% of cases in which HPV16 or 18DNA was positive, a finding suggesting that HPV16 or 18 may play an important role in cervical adenocarcinomas. Overexpression of p16(INK4a) may be an indicator of pathogenic activity of high-risk HPVs.
引用
收藏
页码:378 / 385
页数:8
相关论文
共 47 条
  • [1] The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
    Andersson, S
    Rylander, E
    Larsson, B
    Strand, A
    Silfversvärd, C
    Wilander, E
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (02) : 246 - 250
  • [2] Procedure for immunocytochemical of P16INK4A antigen in thin-layer, liquid-based specimens
    Bibbo, M
    Klump, WJ
    DeCecco, J
    Kovatich, AJ
    [J]. ACTA CYTOLOGICA, 2002, 46 (01) : 25 - 29
  • [3] Tumor suppressors and oncogenes in cellular senescence
    Bringold, F
    Serrano, M
    [J]. EXPERIMENTAL GERONTOLOGY, 2000, 35 (03) : 317 - 329
  • [4] FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA
    CALDAS, C
    HAHN, SA
    DACOSTA, LT
    REDSTON, MS
    SCHUTTE, M
    SEYMOUR, AB
    WEINSTEIN, CL
    HRUBAN, RH
    YEO, CJ
    KERN, SE
    [J]. NATURE GENETICS, 1994, 8 (01) : 27 - 32
  • [5] Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan
    Chen, RJ
    Lin, YH
    Chen, CA
    Huang, SC
    Chow, SN
    Hsieh, CY
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (02) : 184 - 190
  • [6] Ferguson AW, 1998, MODERN PATHOL, V11, P11
  • [7] THE MAJOR E6/E7 TRANSCRIPT OF HPV-16 IN EXFOLIATED CELLS FROM CERVICAL NEOPLASIA PATIENTS
    FUJII, T
    TSUKAZAKI, K
    KIGUCHI, K
    KUBUSHIRO, K
    YAJIMA, M
    NOZAWA, S
    [J]. GYNECOLOGIC ONCOLOGY, 1995, 58 (02) : 210 - 215
  • [8] SIMULTANEOUS DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUS DNA USING THE POLYMERASE CHAIN-REACTION
    FUJINAGA, Y
    SHIMADA, M
    OKAZAWA, K
    FUKUSHIMA, M
    KATO, I
    FUJINAGA, K
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1039 - 1044
  • [9] Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy
    Irie, T
    Kigawa, J
    Minagawa, Y
    Itamochi, H
    Sato, S
    Akeshima, R
    Terakawa, N
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (05): : 464 - 467
  • [10] Iwasawa A, 1996, CANCER-AM CANCER SOC, V77, P2275, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2275::AID-CNCR14>3.3.CO